19th Annual New York Lung Cancers Symposium®

Breakfast & Non-CME Product Theater

Welcome, Introductions, and Presession Survey

Setting the Stage: Challenges in Early-Stage Lung Cancers

The Other EGFRs: Exon 20 Insertions and More

Targeted Therapy in Early-Stage Lung Cancers

Lunch & Non-CE OncLive® Seminar: Updates in Treatment Approaches for Advanced EGFRm NSCLC

Lunch & Non-CE Product Theatre: Breaking New Ground: TTFields Now Approved in a New Indication

Lunch Session for Nurse Practitioners and Physician Assistants

Should You Stop Immunotherapy if It's Working?

You Found the Driver: Upfront Targeted Therapy or Chemotherapy/IO?

KRAS-Targeted Therapy or Taxanes After Chemotherapy/IO?

ADCs for Patients With an Oncogenic Driver